Literature DB >> 21543552

Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis.

Flavia Nelson1, Sushmita Datta, Nereyda Garcia, Nigel L Rozario, Francisco Perez, Gary Cutter, Ponnada A Narayana, Jerry S Wolinsky.   

Abstract

BACKGROUND: Accurate classification of multiple sclerosis (MS) lesions in the brain cortex may be important in understanding their impact on cognitive impairment (CI). Improved accuracy in identification/classification of cortical lesions was demonstrated in a study combining two magnetic resonance imaging (MRI) sequences: double inversion recovery (DIR) and T1-weighted phase-sensitive inversion recovery (PSIR).
OBJECTIVE: To evaluate the role of intracortical lesions (IC) in MS-related CI and compare it with the role of mixed (MX), juxtacortical (JX), the sum of IC + MX and with total lesions as detected on DIR/PSIR images. Correlations between CI and brain atrophy, disease severity and disease duration were also sought.
METHODS: A total of 39 patients underwent extensive neuropsychological testing and were classified into normal and impaired groups. Images were obtained on a 3T scanner and cortical lesions were assessed blind to the cognitive status of the subjects.
RESULTS: Some 238 cortical lesions were identified (130 IC, 108 MX) in 82% of the patients; 39 JX lesions were also identified. Correlations between CI and MX lesions alone (p = 0.010) and with the sum of IC + MX lesions (p = 0.030) were found. A correlation between severity of CI and Expanded Disability Status Scale was also seen (p = 0.009).
CONCLUSION: Cortical lesions play an important role in CI. However, our results suggest that lesions that remain contained within the cortical ribbon do not play a more important role than ones extending into the adjacent white matter; furthermore, the size of the cortical lesion, and not the tissue-specific location, may better explain their correlation with CI.

Entities:  

Mesh:

Year:  2011        PMID: 21543552      PMCID: PMC3151473          DOI: 10.1177/1352458511405561

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  36 in total

1.  Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis.

Authors:  S G Edwards; C Liu; L D Blumhardt
Journal:  Acta Neurol Scand       Date:  2001-10       Impact factor: 3.209

2.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

3.  Multiple memory deficits in patients with multiple sclerosis. Exploring the working memory system.

Authors:  I Litvan; J Grafman; P Vendrell; J M Martinez; C Junqué; J M Vendrell; J L Barraquer-Bordas
Journal:  Arch Neurol       Date:  1988-06

4.  Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI Analysis Center of the University of Texas-Houston, Health Science Center, and the North American Linomide Investigators.

Authors:  J S Wolinsky; P A Narayana; J H Noseworthy; F D Lublin; J N Whitaker; A Linde; P Gjörstrup; H C Sullivan
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

5.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.

Authors:  R Zivadinov; J Sepcic; D Nasuelli; R De Masi; L M Bragadin; M A Tommasi; S Zambito-Marsala; R Moretti; A Bratina; M Ukmar; R S Pozzi-Mucelli; A Grop; G Cazzato; M Zorzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

6.  Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets.

Authors:  Arnaud Charil; Alex P Zijdenbos; Jonathan Taylor; Cyrus Boelman; Keith J Worsley; Alan C Evans; Alain Dagher
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

7.  Cognitive presentation of multiple sclerosis: evidence for a cortical variant.

Authors:  M Zarei; S Chandran; A Compston; J Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

8.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

Authors:  Ralph H B Benedict; Bianca Weinstock-Guttman; Inna Fishman; Jitendra Sharma; Christopher W Tjoa; Rohit Bakshi
Journal:  Arch Neurol       Date:  2004-02

9.  Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR.

Authors:  Olga Ciccarelli; Peter A Brex; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  33 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

2.  Frontal aslant tracts as correlates of lexical retrieval in MS.

Authors:  Zafer Keser; Argye E Hillis; Paul E Schulz; Khader M Hasan; Flavia M Nelson
Journal:  Neurol Res       Date:  2020-06-19       Impact factor: 2.448

Review 3.  Current and new directions in MRI in multiple sclerosis.

Authors:  Eric C Klawiter
Journal:  Continuum (Minneap Minn)       Date:  2013-08

Review 4.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

Review 5.  MRI and multiple sclerosis--the evolving role of MRI in the diagnosis and management of MS: the radiologist's perspective.

Authors:  Alexis M Cahalane; Hugh Kearney; Yvonne M Purcell; Christopher McGuigan; Ronan P Killeen
Journal:  Ir J Med Sci       Date:  2017-11-25       Impact factor: 1.568

6.  Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.

Authors:  E S Beck; P Sati; V Sethi; T Kober; B Dewey; P Bhargava; G Nair; I C Cortese; D S Reich
Journal:  AJNR Am J Neuroradiol       Date:  2018-02-08       Impact factor: 3.825

Review 7.  [Ultrahigh field MRI in context of neurological diseases].

Authors:  J Kuchling; T Sinnecker; I Bozin; J Dörr; V I Madai; J Sobesky; T Niendorf; F Paul; J Wuerfel
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

8.  Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.

Authors:  L E Jonkman; R Klaver; L Fleysher; M Inglese; J J G Geurts
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

9.  Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.

Authors:  A Scott Nielsen; Revere P Kinkel; Nancy Madigan; Emanuele Tinelli; Thomas Benner; Caterina Mainero
Journal:  Neurology       Date:  2013-07-17       Impact factor: 9.910

10.  Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.

Authors:  Flavia Nelson; Mohammad A Akhtar; Edward Zúñiga; Carlos A Perez; Khader M Hasan; Jeffrey Wilken; Jerry S Wolinsky; Ponnada A Narayana; Joel L Steinberg
Journal:  Mult Scler       Date:  2016-09-09       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.